Assisted Reproductive Technology Art Market
Assisted Reproductive Technology (ART) Market Forecasts to 2030 - Global Analysis By Product (Instrument, Accessory & Disposable, Reagents & Media and Other Products), Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking and Other Procedures), Technology, End User and by Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $29.01 BN |
|
Projected Year Value (2030) |
US $57.99 BN |
|
CAGR (2023 - 2030) |
10.4% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Europe |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Assisted Reproductive Technology (ART) Market is accounted for $29.01 billion in 2023 and is expected to reach $57.99 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Assisted Reproductive Technology (ART) describes a variety of medical treatments intended to help individuals or couples become pregnant in cases where conventional methods are not successful. Intrauterine insemination (IUI), in vitro fertilization (IVF), and fertility drugs are all included under this general term. Moreover, reproductive medicine has changed dramatically as a result of ART, which gives hope to those who are infertile or have trouble getting pregnant.
According to the data published on female infertility in the National Library of Medicines in December 2022, globally, 11% of women who had a previous live birth were unable to have another, and 2% of women aged 20 to 44 were unable to have any live births at all.
-Market-fig-2.png)
Market Dynamics:
Driver:
Growing rates of infertility
Infertility rates are rising, and the causes are largely related to modern lifestyles characterized by high levels of stress, sedentary behavior, and environmental variables. Additionally, medical disorders like endometriosis and polycystic ovarian syndrome (PCOS) greatly raise the incidence of infertility. The need for assisted reproductive technology (ART) is growing as more people and couples struggle to conceive naturally, highlighting these interventions as essential remedies for fertility problems.
Restraint:
Restricted success rates
Even though success rates for ART procedures—particularly in vitro fertilization—have increased due to technological advancements, pregnancy is not a given with these procedures. Furthermore, the effectiveness of these interventions may be limited by individual differences in response to treatments as well as by age and underlying medical conditions. For those considering ART, the fact that there are inherent uncertainties and varying success rates continues to be a major deterrent.
Opportunity:
Increasing cryopreservation's uses
Reproductive materials, such as eggs, sperm, and embryos, can have their viability extended through cryopreservation techniques like vitrification. Moreover, better synchronization with people's life decisions and circumstances is made possible by this. With the ability to store fertility for later use, cryopreservation's growing applications help people plan their families with more flexibility.
Threat:
Multiple pregnancy risks
The health of the mother and fetus are at risk due to the possibility of multiple pregnancies that are linked to certain ART procedures. Furthermore, preterm birth and low birth weight are two complications that increase health risks for mothers and their unborn children when they result from multiple pregnancies. In the field, reducing these risks without sacrificing high success rates is an ongoing challenge.
Covid-19 Impact:
The market for assisted reproductive technologies (ART) has been impacted by the COVID-19 pandemic. One could argue that the industry suffered a temporary setback when lockdowns and restrictions on non-essential medical procedures caused a temporary decline in fertility treatments. Nevertheless, there has been a noticeable uptick in demand for ART services as healthcare systems have adjusted to the new normal. Due to people re-evaluating their priorities and perhaps becoming more interested in family planning, the pandemic brought attention to the significance of reproductive health. Furthermore, improvements in virtual consultations and telehealth emerged as a benefit, providing a more convenient and approachable method of fertility treatment.
The In Vitro-fertilization (IVF) segment is expected to be the largest during the forecast period
In vitro fertilization (IVF) is the market segment with the largest share within Assisted Reproductive Technologies (ART). During in vitro fertilization (IVF), an egg is fertilized with sperm outside of the body, and the resultant embryo is then inserted into the uterus. Due to its adaptability and high success rates, this technique has become very popular and is now the preferred choice for singles and couples dealing with infertility issues. Moreover, when it comes to male factor infertility, fallopian tube disorders, and infertility that remains unexplained, infertility treatment with IVF is especially successful.
The Fertility Clinics segment is expected to have the highest CAGR during the forecast period
The market segment with the highest CAGR is fertility clinics. Providers of assisted reproductive technologies (ART), such as IVF and IUI, as well as other fertility treatments, are the focus of fertility clinics. They also offer complete reproductive healthcare services. In addition, the fertility clinic market has experienced strong growth due to the rising demand for these specialized services as well as improvements in ART procedures and technology. Additionally, a committed and targeted approach to reproductive care is provided by fertility clinics, which attract individuals and couples looking for in-depth knowledge of infertility treatments.
Region with largest share:
The largest share of the market for assisted reproductive technology (ART) worldwide is predicted to go to the European region. Well-established healthcare systems and a growing acceptance of fertility treatments are features of European nations like the United Kingdom, Germany, France, and Spain. A vast array of ART procedures are supported by the region's progressive regulatory frameworks, skilled reproductive specialists, and network of cutting-edge fertility clinics. Furthermore, Europe is still a major player in the global ART market, offering a wide range of reproductive services and encouraging improvements in the field of reproductive medicine.
Region with highest CAGR:
In the global assisted reproductive technology (ART) market, the Asia-Pacific region is projected to have the highest CAGR. This region, which includes China, India, and Japan, has seen a notable increase in the demand for reproductive treatments. The high growth in Asia-Pacific is attributed to a number of factors, including rising rates of infertility, rising acceptance of assisted reproductive technologies, and advancements in healthcare infrastructure. Additionally, encouraging government programs and shifting public perceptions of family planning are factors driving the rapid expansion of the ART market in Asia-Pacific.
Key players in the market
Some of the key players in Assisted Reproductive Technology (ART) market include Ferring B.V., Apollo Hospitals Enterprise Ltd., INVO Bioscience, Laboratoire CCD, Nidacon International AB, Fujifilm Holdings Corporation, Bloom Fertility Centre, Inception Sciences, Inc., Thermo Fisher Scientific, Inc, Oxford Gene Technology Ip Ltd, Vitrolife AB, California Cryobank, Hamilton Thorne Inc., Merck KGaA, CooperSurgical Inc. and OvaScience Inc.
Key Developments:
In November 2023, Apollo Hospitals Enterprise Limited will invest around Rs 3,435 crore over the next three years to add 2,300 beds in metros and major cities in different parts of the country. The leading healthcare chain is also looking at Operations and Management agreements overseas in Indonesia and Tanzania, though it will not be investing for the purpose.
In November 2023, Japanese conglomerate Fujifilm Holdings Corp and US pharma giant Bristol Myers Squibb Co have agreed to buy the entire output of a 270-MW solar project being developed by National Grid Renewables in Texas. Each of the two companies has sealed virtual power purchase agreements (PPAs) with the Minneapolis, Minnesota-based renewable energy developer, the latter said on Wednesday.
In October 2023, INVO Bioscience, Inc., a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and NAYA Biosciences Inc., a company dedicated to increasing patient access to breakthrough treatments in oncology and regenerative medicine, today jointly announced that they have entered into a definitive merger agreement for INVO to acquire NAYA Biosciences in an all-stock transaction.
Products Covered:
• Instrument
• Accessory & Disposable
• Reagents & Media
• Other Products
Procedures Covered:
• Fresh Donor
• Fresh Nondonor
• Frozen Donor
• Frozen Nondonor
• Embryo/Egg Banking
• Other Procedures
Technologies Covered:
• In Vitro-fertilization (IVF)
• Artificial Insemination - Intrauterine Insemination (AI-IUI)
• Frozen Embryo Replacement (FER)
• Surrogacy
• Ovulation Induction
• Other Technologies
End Users Covered:
• Hospital
• Fertility Clinics
• Surgical Center
• Clinical Research Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Assisted Reproductive Technology (ART) Market, By Product
5.1 Introduction
5.2 Instrument
5.2.1 Sperm Separation System
5.2.2 Cryosystem
5.2.3 Incubator
5.2.4 Imaging System
5.2.5 Ovum Aspiration Pump
5.2.6 Cabinet
5.2.7 Micromanipulator
5.2.8 Laser Systems
5.3 Accessory & Disposable
5.4 Reagents & Media
5.4.1 Cryopreservation Media
5.4.2 Semen Processing Media
5.4.3 Ovum Processing Media
5.4.4 Embryo Culture Media
5.5 Other Products
6 Global Assisted Reproductive Technology (ART) Market, By Procedure
6.1 Introduction
6.2 Fresh Donor
6.3 Fresh Nondonor
6.4 Frozen Donor
6.5 Frozen Nondonor
6.6 Embryo/Egg Banking
6.7 Other Procedures
7 Global Assisted Reproductive Technology (ART) Market, By Technology
7.1 Introduction
7.2 In Vitro-fertilization (IVF)
7.2.1 IVF with Intracytoplasmic Sperm Injection (ICSI)
7.2.2 IVF without ICSI
7.3 Artificial Insemination - Intrauterine Insemination (AI-IUI)
7.4 Frozen Embryo Replacement (FER)
7.5 Surrogacy
7.6 Ovulation Induction
7.7 Other Technologies
8 Global Assisted Reproductive Technology (ART) Market, By End User
8.1 Introduction
8.2 Hospital
8.3 Fertility Clinics
8.4 Surgical Center
8.5 Clinical Research Institutes
8.6 Other End Users
9 Global Assisted Reproductive Technology (ART) Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Ferring B.V.
11.2 Apollo Hospitals Enterprise Ltd.
11.3 INVO Bioscience
11.4 Laboratoire CCD
11.5 Nidacon International AB
11.6 Fujifilm Holdings Corporation
11.7 Bloom Fertility Centre
11.8 Inception Sciences, Inc.
11.9 Thermo Fisher Scientific, Inc
11.10 Oxford Gene Technology Ip Ltd
11.11 Vitrolife AB
11.12 California Cryobank
11.13 Hamilton Thorne Inc.
11.14 Merck KGaA
11.15 CooperSurgical Inc.
11.16 OvaScience Inc.
List of Tables
1 Global Assisted Reproductive Technology (ART) Market Outlook, By Region (2021-2030) ($MN)
2 Global Assisted Reproductive Technology (ART) Market Outlook, By Product (2021-2030) ($MN)
3 Global Assisted Reproductive Technology (ART) Market Outlook, By Instrument (2021-2030) ($MN)
4 Global Assisted Reproductive Technology (ART) Market Outlook, By Sperm Separation System (2021-2030) ($MN)
5 Global Assisted Reproductive Technology (ART) Market Outlook, By Cryosystem (2021-2030) ($MN)
6 Global Assisted Reproductive Technology (ART) Market Outlook, By Incubator (2021-2030) ($MN)
7 Global Assisted Reproductive Technology (ART) Market Outlook, By Imaging System (2021-2030) ($MN)
8 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovum Aspiration Pump (2021-2030) ($MN)
9 Global Assisted Reproductive Technology (ART) Market Outlook, By Cabinet (2021-2030) ($MN)
10 Global Assisted Reproductive Technology (ART) Market Outlook, By Micromanipulator (2021-2030) ($MN)
11 Global Assisted Reproductive Technology (ART) Market Outlook, By Laser Systems (2021-2030) ($MN)
12 Global Assisted Reproductive Technology (ART) Market Outlook, By Accessory & Disposable (2021-2030) ($MN)
13 Global Assisted Reproductive Technology (ART) Market Outlook, By Reagents & Media (2021-2030) ($MN)
14 Global Assisted Reproductive Technology (ART) Market Outlook, By Cryopreservation Media (2021-2030) ($MN)
15 Global Assisted Reproductive Technology (ART) Market Outlook, By Semen Processing Media (2021-2030) ($MN)
16 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovum Processing Media (2021-2030) ($MN)
17 Global Assisted Reproductive Technology (ART) Market Outlook, By Embryo Culture Media (2021-2030) ($MN)
18 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Products (2021-2030) ($MN)
19 Global Assisted Reproductive Technology (ART) Market Outlook, By Procedure (2021-2030) ($MN)
20 Global Assisted Reproductive Technology (ART) Market Outlook, By Fresh Donor (2021-2030) ($MN)
21 Global Assisted Reproductive Technology (ART) Market Outlook, By Fresh Nondonor (2021-2030) ($MN)
22 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Donor (2021-2030) ($MN)
23 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Nondonor (2021-2030) ($MN)
24 Global Assisted Reproductive Technology (ART) Market Outlook, By Embryo/Egg Banking (2021-2030) ($MN)
25 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Procedures (2021-2030) ($MN)
26 Global Assisted Reproductive Technology (ART) Market Outlook, By Technology (2021-2030) ($MN)
27 Global Assisted Reproductive Technology (ART) Market Outlook, By In Vitro-fertilization (IVF) (2021-2030) ($MN)
28 Global Assisted Reproductive Technology (ART) Market Outlook, By IVF with Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
29 Global Assisted Reproductive Technology (ART) Market Outlook, By IVF without ICSI (2021-2030) ($MN)
30 Global Assisted Reproductive Technology (ART) Market Outlook, By Artificial Insemination - Intrauterine Insemination (AI-IUI) (2021-2030) ($MN)
31 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Embryo Replacement (FER) (2021-2030) ($MN)
32 Global Assisted Reproductive Technology (ART) Market Outlook, By Surrogacy (2021-2030) ($MN)
33 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovulation Induction (2021-2030) ($MN)
34 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Technologies (2021-2030) ($MN)
35 Global Assisted Reproductive Technology (ART) Market Outlook, By End User (2021-2030) ($MN)
36 Global Assisted Reproductive Technology (ART) Market Outlook, By Hospital (2021-2030) ($MN)
37 Global Assisted Reproductive Technology (ART) Market Outlook, By Fertility Clinics (2021-2030) ($MN)
38 Global Assisted Reproductive Technology (ART) Market Outlook, By Surgical Center (2021-2030) ($MN)
39 Global Assisted Reproductive Technology (ART) Market Outlook, By Clinical Research Institutes (2021-2030) ($MN)
40 Global Assisted Reproductive Technology (ART) Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
